4Vinik A. Diabetic Neuropathy: Pathogenesis and Therapy. Am J Med,1999, 107(2B): 17S- 26S.
5Zochodne DW. Diabetic neuropathies: features and mechanisms. Brain Pathol, 1999, 9(2): 369-391.
6Harati Y. Diabetes and the Nervous System. Chronic Complications of Diabetes, 1996, 25(2): 325- 359.
7Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes, 1997, 46 (Suppl 2): S31 -S37.
8Giannini C, Dyck PJ. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol, 1995, 37(4): 498- 504.
9Shindo H, Thomas TP, Larkin DD, et al. Modulation of basal nitric oxide - dependent, cyclic - GMP production by ambient glocose, myoinositol, and protein kinase C in SH- SY5Y human neuroblastoma cells. J Clin Invest, 1996, 97(3): 736- 745.
10Cameron NE, Cotter MA. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract, 1999,45(2-3): 137- 146.
